Report overview
This report contains market size and forecasts of Orphan Drugs in global, including the following market information:
Global Orphan Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Orphan Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Orphan Drugs companies in 2021 (%)
The global Orphan Drugs market was valued at 126280 million in 2021 and is projected to reach US$ 235070 million by 2028, at a CAGR of 9.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oncology Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Orphan Drugs include Novartis, Bristol-Myers Squibb Company, Celgene, F. Hoffmann-La Roche, Pfizer, Sanofi, Alexion Pharmaceuticals, Eli Lilly and Company and Novo Nordisk, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Orphan Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Orphan Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Orphan Drugs Market Segment Percentages, by Type, 2021 (%)
Oncology
Gastrointestinal
Pulmonary
Neurology
Hematology
Cardio-vascular
Metabolic Disorders
Endocrinology
Infectious Diseases
Others
Global Orphan Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Orphan Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail pharmacies
Others
Global Orphan Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Orphan Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Orphan Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Orphan Drugs revenues share in global market, 2021 (%)
Key companies Orphan Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Orphan Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Bristol-Myers Squibb Company
Celgene
F. Hoffmann-La Roche
Pfizer
Sanofi
Alexion Pharmaceuticals
Eli Lilly and Company
Novo Nordisk
AstraZeneca
Eisai
Daiichi Sankyo Company
Bayer
GlaxoSmithKline
Merck & Co
Johnson & Johnson
Biogen
Takeda
Amgen
